These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8017963)

  • 41. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome.
    Derks TG; Reijngoud DJ; Waterham HR; Gerver WJ; van den Berg MP; Sauer PJ; Smit GP
    J Pediatr; 2006 May; 148(5):665-670. PubMed ID: 16737882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Public health explores expanding newborn screening for cystic fibrosis, congenital adrenal hyperplasia, and medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD).
    Rhoades E; King P
    J Okla State Med Assoc; 2001 Apr; 94(4):129-32. PubMed ID: 11392180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome.
    Howat AJ; Bennett MJ; Variend S; Shaw L
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):976. PubMed ID: 6423169
    [No Abstract]   [Full Text] [Related]  

  • 44. Neonatal ventricular tachyarrhythmias in medium chain acyl-CoA dehydrogenase deficiency.
    Yusuf K; Jirapradittha J; Amin HJ; Yu W; Hasan SU
    Neonatology; 2010; 98(3):260-4. PubMed ID: 20414003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
    Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
    Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The metabolic crisis: a diagnostic challenge [editoria; comment].
    Bove KE
    J Pediatr; 1997 Aug; 131(2):181-2. PubMed ID: 9290601
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.
    Wilcken B; Haas M; Joy P; Wiley V; Chaplin M; Black C; Fletcher J; McGill J; Boneh A
    Lancet; 2007 Jan; 369(9555):37-42. PubMed ID: 17208640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resuscitation of a neonate with medium chain acyl-coenzyme a dehydrogenase deficiency using extracorporeal life support.
    Kumar G; Mattke AC; Bowling F; McWhinney A; Alphonso N; Karl TR
    World J Pediatr Congenit Heart Surg; 2014 Jan; 5(1):118-20. PubMed ID: 24403369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-chain 3-hydroxyacylCoA dehydrogenase deficiency: a new case presenting with liver dysfunction, cholestasis and fibrosis.
    Odievre MH; Sevin C; Laurent J; Laboureau JP; Rabier D; Brivet M; Roe C; Wanders RJ; Saudubray JM
    Acta Paediatr; 2002; 91(6):719-22. PubMed ID: 12162610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Limitations of 3-phenylpropionylglycine in early screening for medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Bhala A; Bennett MJ; McGowan KL; Hale DE
    J Pediatr; 1993 Jan; 122(1):100-3. PubMed ID: 8419594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency.
    Allen C; Perkins R; Schwahn B
    Paediatr Anaesth; 2017 Jan; 27(1):60-65. PubMed ID: 27896927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
    Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
    Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
    [No Abstract]   [Full Text] [Related]  

  • 54. High risk of medium chain acyl-coenzyme A dehydrogenase deficiency among gypsies.
    Martinez G; Garcia-Lozano JR; Ribes A; Maldonado MD; Baldellou A; de Pablo R; Nuñez-Roldan A
    Pediatr Res; 1998 Jul; 44(1):83-4. PubMed ID: 9667375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid MRI technique for the assessment of hepatic steatosis in a subject with medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency.
    Fishbein M; Smith M; Li BU
    J Pediatr Gastroenterol Nutr; 1998 Aug; 27(2):224-7. PubMed ID: 9702659
    [No Abstract]   [Full Text] [Related]  

  • 56. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
    Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
    Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
    [No Abstract]   [Full Text] [Related]  

  • 57. Late presentation of medium-chain acyl-CoA dehydrogenase deficiency.
    Mayell SJ; Edwards L; Reynolds FE; Chakrapani AB
    J Inherit Metab Dis; 2007 Feb; 30(1):104. PubMed ID: 17143576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatty liver, encephalopathy, and sudden unexpected death in early childhood due to medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Perper JA; Ahdab-Barmada M
    Am J Forensic Med Pathol; 1992 Dec; 13(4):329-34. PubMed ID: 1288265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The frequency of MCAD mutation (K329E) in the Finnish population.
    Schwartz EI; Ilonen J; Skobeleva NA; Akerblom HK
    Eur J Pediatr; 1995 Jun; 154(6):501. PubMed ID: 7671954
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.